{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T05:27:32Z","timestamp":1730870852417,"version":"3.28.0"},"reference-count":30,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1055\/a-1844-9568","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T23:30:26Z","timestamp":1677540626000},"page":"230-240","source":"Crossref","is-referenced-by-count":0,"title":["Autoimmundiagnostik in der Nephrologie und Rheumatologie"],"prefix":"10.1055","volume":"148","author":[{"given":"Heike","family":"Bruck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"von Kiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1055\/a-0976-8893","article-title":"Update Membran\u00f6se Glomerulonephritis","volume":"145","author":"E Hoxha","year":"2020","journal-title":"Dtsch Med Wochenschr"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous\n          nephropathy","volume":"361","author":"LH Beck Jr","year":"2009","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy","volume":"7","author":"P Ronco","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous\n          nephropathy","volume":"371","author":"NM Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11560-019-0319-x","article-title":"Pulmorenales Syndrom","volume":"14","author":"S Vietinghoff","year":"2019","journal-title":"Nephrologe"},{"issue":"S 03","key":"ref7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00393-017-0394-1","article-title":"S1-Leitlinie \u2013 Diagnostik und Therapie der ANCA-assoziierten\n          Vaskulitiden","volume":"76","author":"JH Schirmer","year":"2017","journal-title":"Z Rheumatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","article-title":"Position paper: Revised 2017 international consensus on testing of ANCAs in\n          granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"X Bossuyt","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.autrev.2013.06.014","article-title":"Goodpasture\u2019s disease: A report of ten cases and a review of the\n          literature","volume":"12","author":"F Dammaco","year":"2013","journal-title":"Autoimmun Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jca.21470","article-title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based\n          Approach from the Writing Committee of the American Society for Apheresis: The Seventh\n          Special Issue","volume":"31","author":"J Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jaut.2014.01.024","article-title":"Diagnosis and classification of Goodpasture\u2019s disease (anti-GBM)","volume":"48\u201349","author":"T Hellmark","year":"2014","journal-title":"J Autoimmun"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00393-020-00802-6","article-title":"Antinukle\u00e4re Antik\u00f6rper in der Diagnostik rheumatischer Erkrankungen [Antinuclear\n          antibodies in the diagnostics of rheumatic diseases]","volume":"79","author":"T Rose","year":"2020","journal-title":"Z Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.rdc.2021.04.011","article-title":"Systemic Lupus Erythematosus Classification and Diagnosis","volume":"47","author":"M Aringer","year":"2021","journal-title":"Rheum Dis Clin North Am"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7754\/clin.lab.2015.150905","article-title":"Autoantibodies Against DFS70\/LEDGF Exclusion Markers for Systemic Autoimmune\n          Rheumatic Diseases (SARD)","volume":"62","author":"CA Seelig","year":"2016","journal-title":"Clin Lab"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/ard.2003.013417","article-title":"Specific antinuclear antibodies are associated with clinical features in systemic\n          lupus erythematosus","volume":"63","author":"IE Hoffman","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for\n          definite antiphospholipid syndrome (APS)","volume":"4","author":"S Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11560-021-00487-1","article-title":"Thrombotische Mikroangiopathie \u2013 Diagnose und Therapie","volume":"16","author":"A G\u00e4ckler","year":"2021","journal-title":"Nephrologe"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"100945","DOI":"10.1016\/j.blre.2022.100945","article-title":"Advances in the management of TTP","volume":"55","author":"M Subhan","year":"2022","journal-title":"Blood Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s11560-019-0357-4","article-title":"Charakterisierung von Patienten mit atypischem h\u00e4molytisch- ur\u00e4mischen Syndrom\n          (aHUS) in Deutschland","volume":"14","author":"CS Haas","year":"2019","journal-title":"Nephrologe"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s00108-019-0572-0","article-title":"Membranoproliferative Glomerulonephritis und C3-Glomerulopathie","volume":"60","author":"B Hohenstein","year":"2019","journal-title":"Internist"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrneph.2010.85","article-title":"C3 glomerulopathy: a new classification","volume":"6","author":"F Fakhouri","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"MC Pickering","year":"2013","journal-title":"Kidney Int"},{"issue":"S 01","key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00393-020-00775-6","article-title":"Management der fr\u00fchen rheumatoiden Arthritis: Interdisziplin\u00e4re Leitlinie\n          [Management of early rheumatoid arthritis : Interdisciplinary guideline]","volume":"79","author":"M Schneider","year":"2020","journal-title":"Z Rheumatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00117-006-1360-0","article-title":"Systemische Manifestationen der rheumatoiden Arthritis","volume":"46","author":"M Uffmann","year":"2006","journal-title":"Radiologe"},{"key":"ref27","first-page":"113","article-title":"Rheumatoid factor isotypes and circulating immune complexes in rheumatoid\n          arthritis","volume":"8","author":"GJ Zlabinger","year":"1990","journal-title":"Clin Exp Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/ar95","article-title":"Citrullination: a small change for a protein with great consequences for\n          rheumatoid arthritis","volume":"2","author":"WJ Van Venrooij","year":"2000","journal-title":"Arthritis Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of\n          Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"D Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"728610","DOI":"10.1155\/2015\/728610","article-title":"The role of citrullinated protein antibodies in predicting erosive disease in\n          rheumatoid arthritis: a systematic literature review and meta-analysis","volume":"2015","author":"AA Jilani","year":"2015","journal-title":"Int J Rheumatol"},{"issue":"S 02","key":"ref31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00393-018-0481-y","article-title":"S2e-Leitlinie: Therapie der rheumatoiden Arthritis mit krankheits-modifizierenden\n          Medikamenten [S2e guideline: treatment of rheumatoid arthritis with disease-modifying\n          drugs]","volume":"77","author":"C Fiehn","year":"2018","journal-title":"Z Rheumatol"},{"issue":"S 01","key":"ref32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00393-019-0670-3","article-title":"Langfassung zur S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew\n          und Fr\u00fchformen, Update 2019: Evidenzbasierte Leitlinie der Deutschen Gesellschaft f\u00fcr\n          Rheumatologie (DGRh) und der beteiligten medizinisch-wissenschaftlichen Fachgesellschaften\n          und weiterer Organisationen","volume":"78","author":"U Kiltz","year":"2019","journal-title":"Z Rheumatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1136\/annrheumdis-2012-202208","article-title":"Autoantibodies against CD74 in spondyloarthritis","volume":"73","author":"NT Baerlecken","year":"2014","journal-title":"Ann Rheum Dis"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1844-9568.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:52:29Z","timestamp":1730814749000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1844-9568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":30,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2023,2,27]]},"published-print":{"date-parts":[[2023,3]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1844-9568","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"type":"print","value":"0012-0472"},{"type":"electronic","value":"1439-4413"}],"subject":[],"published":{"date-parts":[[2023,2,27]]}}}